
Exercise and airway clearance techniques (ACTs) have been a cornerstone of treatment for people with cystic fibrosis (pwCF) for many decades. Exercise may confer both respiratory and nonrespiratory benefits for pwCF, with greater exercise capacity associated with improved survival. Therefore, a wide variety of exercise interventions for pwCF have been investigated. With advances in the therapeutic options for pwCF, a rationalization of the therapeutic regimen may be possible. The article summarizes the current evidence for the use of exercise and ACTs by pwCF, discuss the implications of the introduction of cystic fibrosis transmembrane conductance regulator modulators on both exercise and ACTs and highlights areas for further research.
Like
Save
Share